Skip to main content

Peer Review reports

From: Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment

Original Submission
10 Mar 2020 Submitted Original manuscript
21 Mar 2020 Author responded Author comments - Guan-hua Hu
Resubmission - Version 2
21 Mar 2020 Submitted Manuscript version 2
4 Apr 2020 Reviewed Reviewer Report
17 Apr 2020 Reviewed Reviewer Report
29 Apr 2020 Author responded Author comments - Guan-hua Hu
Resubmission - Version 3
29 Apr 2020 Submitted Manuscript version 3
20 May 2020 Reviewed Reviewer Report
27 May 2020 Reviewed Reviewer Report
1 Jun 2020 Author responded Author comments - Guan-hua Hu
Resubmission - Version 4
1 Jun 2020 Submitted Manuscript version 4
2 Jun 2020 Author responded Author comments - Guan-hua Hu
Resubmission - Version 5
2 Jun 2020 Submitted Manuscript version 5
Publishing
4 Jun 2020 Editorially accepted
15 Jun 2020 Article published 10.1186/s12885-020-07043-5

You can find further information about peer review here.

Back to article page